查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美的全EXOME定序市場 - 產業趨勢和至2029年的預測
市場調查報告書
商品編碼
1100138

北美的全EXOME定序市場 - 產業趨勢和至2029年的預測

NA Whole Exome Sequencing Market - Industry Trends and Forecast to 2029
出版日期: | 出版商: Data Bridge Market Research | 英文 175 Pages | 商品交期: 請詢問到貨日

價格

北美的全EXOME定序的市場規模，預計在2022年～2029年的預測期間中以22.0％大幅度的年複合成長率擴大。

本報告提供北美的全EXOME定序市場相關調查，市場概要，以及各零件，各產品、服務，各用途，各終端用戶，各流通管道，各地區的趨勢，及加入此市場的主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

第5章 北美的全EXOME定序市場:法規

第6章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第7章 北美的全EXOME定序市場，各零件

  • 概要
  • 第2代的定序
  • 第3代定序

第8章 北美的全EXOME定序市場，產品、各服務

  • 概要
  • 系統
  • 套件
  • 服務

第9章 北美的全EXOME定序市場，各用途

  • 概要
  • 藥物研發、開發
  • 農業、動物研究
  • 診斷
  • 個人化醫療
  • 其他

第10章 北美的全EXOME定序市場，各終端用戶

  • 概要
  • 製藥公司及生物科技企業
  • 學術研究機關
  • 醫院、診所
  • 臨床檢驗室
  • 其他

第11章 北美的全EXOME定序市場，各流通管道

  • 概要
  • 直接交易
  • 零售
  • 其他

第12章 北美的全EXOME定序市場，各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥

第13章 北美的全EXOME定序市場:企業形勢

  • 企業佔有率分析:北美

第14章 企業簡介

  • PERKINELMER GENOMICS
  • MERCK KGAA
  • EXODX(A PART OF BIO-TECHNE)
  • THERMO FISHER SCIENTIFIC INC.
  • FOUNDATION MEDICINE, INC.
  • AZENTA US, INC.
  • BECKMAN COULTER, INC
  • BIONEER CORPORATION
  • CD GENOMICS
  • CEGAT GMBH
  • EUROFINS SCIENTIFIC
  • GENEDX, LLC
  • GENEFIRST LIMITED.
  • ILLUMINA, INC
  • INTEGRATED DNA TECHNOLOGIES, INC.
  • MERIDIAN BIOSCIENCE, INC.
  • PSOMAGEN
  • QIAGEN
  • SOPHIA GENETICS
  • TWIST BIOSCIENCE

第15章 問卷調查

第16章 相關報告

North America whole exome sequencing (WES) Market is projected to register a substantial CAGR of 22.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.

Market Segmentation:

Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.

North America Whole Exome Sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.

On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.

On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.

On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.

On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.

On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.

Some of the major factors contributing to the growth of the North America whole exome sequencing (WES) market are:

Increase in the adoption of whole exome sequencing (WES)

Growing usage of targeted sequencing methods

Market Players:

The key market players for North America whole exome sequencing (WES) market are listed below:

CD Genomics

Twist Bioscience

PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.)

GeneDx, LLC

Psomagen

TABLE OF CONTENTS

1 INTRODUCTION 33

  • 1.1 OBJECTIVES OF THE STUDY 33
  • 1.2 MARKET DEFINITION 33
  • 1.3 OVERVIEW OF NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET 33
  • 1.4 CURRENCY AND PRICING 35
  • 1.5 LIMITATIONS 35
  • 1.6 MARKETS COVERED 36

2 MARKET SEGMENTATION 39

  • 2.1 MARKETS COVERED 39
  • 2.2 GEOGRAPHICAL SCOPE 40
  • 2.3 YEARS CONSIDERED FOR THE STUDY 41
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 42
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
  • 2.6 MULTIVARIATE MODELLING 46
  • 2.7 MARKET APPLICATION COVERAGE GRID 47
  • 2.8 PRODUCT TYPE LIFELINE CURVE 48
  • 2.9 DBMR MARKET POSITION GRID 49
  • 2.10 VENDOR SHARE ANALYSIS 51
  • 2.11 SECONDARY SOURCES 52
  • 2.12 ASSUMPTIONS 52

3 EXECUTIVE SUMMARY 53

4 PREMIUM INSIGHT 57

  • 4.1 PORTER'S FIVE FORCES 58
  • 4.2 PESTEL ANALYSIS 59
  • 4.3 INDUSTRIAL INSIGHTS: 60
  • 4.4 CONCLUSION 61

5 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: REGULATIONS 62

6 MARKET OVERVIEW 64

  • 6.1 DRIVERS 66
    • 6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS 66
    • 6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING 66
    • 6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING 66
    • 6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION 67

 

  • 6.2 RESTRAINTS 68
    • 6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS 68
    • 6.2.2 CYBER SECURITY CONCERNS IN GENOMICS 68
  • 6.3 OPPORTUNITIES 69
    • 6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 69
    • 6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS 69
  • 6.4 CHALLENGES 70
    • 6.4.1 LACK OF SKILLED PROFESSIONALS 70
    • 6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING 70

7 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT 71

  • 7.1 OVERVIEW 72
  • 7.2 SECOND-GENERATION SEQUENCING 75
    • 7.2.1 SEQUENCING BY SYNTHESIS (SBS) 76
    • 7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL) 76
  • 7.3 THIRD-GENERATION SEQUENCING 77

8 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE 78

  • 8.1 OVERVIEW 79
  • 8.2 SYSTEMS 82
    • 8.2.1 HISEQ SERIES 83
      • 8.2.1.1 HISEQ 2500 83
      • 8.2.1.2 HISEQ 1500 83
    • 8.2.2 MISEQ SERIES 83
    • 8.2.3 ION TORRENT PLATFORMS 84
      • 8.2.3.1 ION PROTON 84
      • 8.2.3.2 ION PGM 84
    • 8.2.4 OTHERS 84
  • 8.3 KITS 84
    • 8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 85
    • 8.3.2 LIBRARY PREPARATION KITS 85
    • 8.3.3 TARGET ENRICHMENT KITS 86
    • 8.3.4 OTHERS 86
  • 8.4 SERVICES 86
    • 8.4.1 SEQUENCING SERVICES 87
    • 8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES 87
    • 8.4.3 OTHERS 87

 

9 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 88

  • 9.1 OVERVIEW 89
  • 9.2 DRUG DISCOVERY AND DEVELOPMENT 92
  • 9.3 AGRICULTURE & ANIMAL RESEARCH 93
  • 9.4 DIAGNOSTICS 93
  • 9.5 PERSONALIZED MEDICINE 94
  • 9.6 OTHERS 95

10 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER 96

  • 10.1 OVERVIEW 97
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
  • 10.3 ACADEMIC & RESEARCH INSTITUTES 101
  • 10.4 HOSPITALS AND CLINICS 101
  • 10.5 CLINICAL LABORATORIES 102
  • 10.6 OTHERS 103

11 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL 104

  • 11.1 OVERVIEW 105
  • 11.2 DIRECT TRADE 108
  • 11.3 RETAIL SALES 108
  • 11.4 OTHERS 110

12 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY REGION 111

  • 12.1 NORTH AMERICA 112
    • 12.1.1 U.S. 120
    • 12.1.2 CANADA 123
    • 12.1.3 MEXICO 126

13 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE 129

  • 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 129

14 COMPANY PROFILE 130

  • 14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.) 130
    • 14.1.1 COMPANY SNAPSHOT 130
    • 14.1.2 REVENUE ANALYSIS 130
    • 14.1.3 COM PANY SHARE ANALYSIS 131
    • 14.1.4 PRODUCT PORTFOLIO 131
    • 14.1.5 RECENT DEVELOPMENTS 131

 

  • 14.2 MERCK KGAA 133
    • 14.2.1 COMPANY SNAPSHOT 133
    • 14.2.2 REVENUE ANALYSIS 133
    • 14.2.3 COM PANY SHARE ANALYSIS 134
    • 14.2.4 PRODUCT PORTFOLIO 134
    • 14.2.5 RECENT DEVELOPMENTS 134
  • 14.3 EXODX (A PART OF BIO-TECHNE) 135
    • 14.3.1 COMPANY SNAPSHOT 135
    • 14.3.2 REVENUE ANALYSIS 135
    • 14.3.3 COM PANY SHARE ANALYSIS 136
    • 14.3.4 PRODUCT PORTFOLIO 136
    • 14.3.5 RECENT DEVELOPMENTS 136
  • 14.4 THERMO FISHER SCIENTIFIC INC. 137
    • 14.4.1 COMPANY SNAPSHOT 137
    • 14.4.2 REVENUE ANALYSIS 137
    • 14.4.3 COM PANY SHARE ANALYSIS 138
    • 14.4.4 PRODUCT PORTFOLIO 138
    • 14.4.5 RECENT DEVELOPMENTS 138
  • 14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 139
    • 14.5.1 COMPANY SNAPSHOT 139
    • 14.5.2 REVENUE ANALYSIS 139
    • 14.5.3 COM PANY SHARE ANALYSIS 140
    • 14.5.4 PRODUCT PORTFOLIO 140
    • 14.5.5 RECENT DEVELOPMENTS 140
  • 14.6 AZENTA US, INC. 142
    • 14.6.1 COMPANY SNAPSHOT 142
    • 14.6.2 PRODUCT PORTFOLIO 142
    • 14.6.3 RECENT DEVELOPMENTS 142
  • 14.7 BECKMAN COULTER, INC 144
    • 14.7.1 COMPANY SNAPSHOT 144
    • 14.7.2 REVENUE ANALYSIS 144
    • 14.7.3 PRODUCT PORTFOLIO 145
    • 14.7.4 RECENT DEVELOPMENTS 145
  • 14.8 BIONEER CORPORATION 146
    • 14.8.1 COMPANY SNAPSHOT 146
    • 14.8.2 REVENUE ANALYSIS 146
    • 14.8.3 PRODUCT PORTFOLIO 147
    • 14.8.4 RECENT DEVELOPMENTS 147

 

  • 14.9 CD GENOMICS 148
    • 14.9.1 COMPANY SNAPSHOT 148
    • 14.9.2 PRODUCT PORTFOLIO 148
    • 14.9.3 RECENT DEVELOPMENTS 148
  • 14.10 CEGAT GMBH 149
    • 14.10.1 COMPANY SNAPSHOT 149
    • 14.10.2 PRODUCT PORTFOLIO 149
    • 14.10.3 RECENT DEVELOPMENTS 149
  • 14.11 EUROFINS SCIENTIFIC 150
    • 14.11.1 COMPANY SNAPSHOT 150
    • 14.11.2 REVENUE ANALYSIS 150
    • 14.11.3 PRODUCT PORTFOLIO 151
    • 14.11.4 RECENT DEVELOPMENTS 151
  • 14.12 GENEDX, LLC 152
    • 14.12.1 COMPANY SNAPSHOT 152
    • 14.12.2 PRODUCT PORTFOLIO 152
    • 14.12.3 RECENT DEVELOPMENTS 152
  • 14.13 GENEFIRST LIMITED. 154
    • 14.13.1 COMPANY SNAPSHOT 154
    • 14.13.2 PRODUCT PORTFOLIO 154
    • 14.13.3 RECENT DEVELOPMENTS 154
  • 14.14 ILLUMINA, INC 156
    • 14.14.1 COMPANY SNAPSHOT 156
    • 14.14.2 REVENUE ANALYSIS 156
    • 14.14.3 PRODUCT PORTFOLIO 157
    • 14.14.4 RECENT DEVELOPMENTS 157
  • 14.15 INTEGRATED DNA TECHNOLOGIES, INC. 159
    • 14.15.1 COMPANY SNAPSHOT 159
    • 14.15.2 PRODUCT PORTFOLIO 159
    • 14.15.3 RECENT DEVELOPMENTS 159
  • 14.16 MERIDIAN BIOSCIENCE, INC. 161
    • 14.16.1 COMPANY SNAPSHOT 161
    • 14.16.2 REVENUE ANALYSIS 161
    • 14.16.3 PRODUCT PORTFOLIO 162
    • 14.16.4 RECENT DEVELOPMENTS 162
  • 14.17 PSOMAGEN 163
    • 14.17.1 COMPANY SNAPSHOT 163
    • 14.17.2 REVENUE ANALYSIS 163
    • 14.17.3 PRODUCT PORTFOLIO 163
    • 14.17.4 RECENT DEVELOPMENTS 164
  • 14.18 QIAGEN 165
    • 14.18.1 COMPANY SNAPSHOT 165
    • 14.18.2 REVENUE ANALYSIS 165
    • 14.18.3 PRODUCT PORTFOLIO 166
    • 14.18.4 RECENT DEVELOPMENTS 166
  • 14.19 SOPHIA GENETICS 167
    • 14.19.1 COMPANY SNAPSHOT 167
    • 14.19.2 REVENUE ANALYSIS 167
    • 14.19.3 PRODUCT PORTFOLIO 168
    • 14.19.4 RECENT DEVELOPMENTS 168
  • 14.20 TWIST BIOSCIENCE 169
    • 14.20.1 COMPANY SNAPSHOT 169
    • 14.20.2 REVENUE ANALYSIS 169
    • 14.20.3 PRODUCT PORTFOLIO 170
    • 14.20.4 RECENT DEVELOPMENTS 170

15 QUESTIONNAIRE 172

16 RELATED REPORTS 175

LIST OF TABLES

  • TABLE 1 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 57
  • TABLE 2 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 58
  • TABLE 3 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 59
  • TABLE 4 NORTH AMERICA THIRD-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 60
  • TABLE 5 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 64
  • TABLE 6 NORTH AMERICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 65
  • TABLE 7 NORTH AMERICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 65
  • TABLE 8 NORTH AMERICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 66
  • TABLE 9 NORTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 67
  • TABLE 10 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 68
  • TABLE 11 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 68
  • TABLE 12 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 69
  • TABLE 13 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 70
  • TABLE 14 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 74
  • TABLE 15 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 75
  • TABLE 16 NORTH AMERICA AGRICULTURE & ANIMAL RESEARCH IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 76
  • TABLE 17 NORTH AMERICA DIAGNOSTICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 18 NORTH AMERICA PERSONALIZED MEDICINE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 19 NORTH AMERICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 20 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 82
  • TABLE 21 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 83
  • TABLE 22 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 23 NORTH AMERICA HOSPITALS AND CLINICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 85
  • TABLE 24 NORTH AMERICA CLINICAL LABORATORIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 86
  • TABLE 25 NORTH AMERICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 86
  • TABLE 26 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 90
  • TABLE 27 NORTH AMERICA DIRECT TRADE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 91
  • TABLE 28 NORTH AMERICA RETAIL SALES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 92
  • TABLE 29 NORTH AMERICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 93
  • TABLE 30 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 99
  • TABLE 31 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 99
  • TABLE 32 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 99
  • TABLE 33 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 99
  • TABLE 34 NORTH AMERICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 100
  • TABLE 35 NORTH AMERICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 100
  • TABLE 36 NORTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 100
  • TABLE 37 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 100
  • TABLE 38 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 101
  • TABLE 39 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 101
  • TABLE 40 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 101
  • TABLE 41 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 102
  • TABLE 42 U.S. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 103
  • TABLE 43 U.S. SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 103
  • TABLE 44 U.S. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 103
  • TABLE 45 U.S. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 103
  • TABLE 46 U.S. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 47 U.S. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 48 U.S. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 49 U.S. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 50 U.S. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 105
  • TABLE 51 U.S. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 105
  • TABLE 52 U.S. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 105
  • TABLE 53 CANADA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 106
  • TABLE 54 CANADA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 106
  • TABLE 55 CANADA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 106
  • TABLE 56 CANADA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 106
  • TABLE 57 CANADA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 107
  • TABLE 58 CANADA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 107
  • TABLE 59 CANADA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 107
  • TABLE 60 CANADA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 107
  • TABLE 61 CANADA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 108
  • TABLE 62 CANADA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 108
  • TABLE 63 CANADA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 108
  • TABLE 64 MEXICO WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 109
  • TABLE 65 MEXICO SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 109
  • TABLE 66 MEXICO WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 67 MEXICO SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 68 MEXICO HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 110
  • TABLE 69 MEXICO ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 110
  • TABLE 70 MEXICO KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 110
  • TABLE 71 MEXICO SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 110
  • TABLE 72 MEXICO WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 111
  • TABLE 73 MEXICO WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 111
  • TABLE 74 MEXICO WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 111

 

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 21
  • FIGURE 2 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION 24
  • FIGURE 3 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS 25
  • FIGURE 4 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 26
  • FIGURE 5 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS 26
  • FIGURE 6 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS 27
  • FIGURE 7 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID 29
  • FIGURE 8 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID 31
  • FIGURE 9 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: VENDOR SHARE ANALYSIS 33
  • FIGURE 10 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 37
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 38
  • FIGURE 12 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 39
  • FIGURE 13 THE INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN 2022 & 2029 39
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA WHOLE EXOME SEQUENCING MARKET 47
  • FIGURE 15 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2021 54
  • FIGURE 16 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION) 55
  • FIGURE 17 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029) 55
  • FIGURE 18 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE 56
  • FIGURE 19 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2021 61
  • FIGURE 20 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022-2029 (USD MILLION) 62
  • FIGURE 21 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2022-2029) 62
  • FIGURE 22 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE 63
  • FIGURE 23 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2021 71
  • FIGURE 24 LOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 72
  • FIGURE 25 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2022-2029) 72
  • FIGURE 26 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE 73
  • FIGURE 27 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2021 79
  • FIGURE 28 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022-2029 (USD MILLION) 80
  • FIGURE 29 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2022-2029) 80
  • FIGURE 30 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE 81
  • FIGURE 31 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2021 87
  • FIGURE 32 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 88
  • FIGURE 33 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 88
  • FIGURE 34 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 89
  • FIGURE 35 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021) 95
  • FIGURE 36 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021) 96
  • FIGURE 37 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029) 96
  • FIGURE 38 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029) 97
  • FIGURE 39 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029) 97
  • FIGURE 40 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%) 111